Amersham Pharmacia Biotech Announces Acquisition of Dan-Process A/S.Business Editors & Health/Medical Writers BIOWIRE2K PISCATAWAY, N.J.--(BW HealthWire)--July 23, 2001 Acquisition of Company Specializing in High-Pressure Chromatography Systems and Columns Will Enhance Capability for Peptide and Peptide Hormone Purification Amersham Pharmacia Biotech today announced the acquisition of the Danish company, Dan-Process A/S, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Pantax. Dan-Process is a well-established supplier of engineering solutions for the purification of biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page , specializing in high-pressure process-scale chromatography systems and columns for the purification of biomolecules such as peptides and peptide hormones. Under the terms of the agreement, Amersham Pharmacia Biotech acquired 100 percent of Dan-Process, which will retain a high degree of autonomy. Financial terms were not disclosed. Peder Dahl, the founder of Dan-Process, will continue to run the day-to-day operations of the company. The product portfolio will be marketed under the Dan-Process brand and be sold through Amersham Pharmacia Biotech's global sales network. "The acquisition of Dan-Process strengthens our Bioprocess bi·o·proc·ess n. 1. A technique that produces a biological material, such as a genetically engineered microbial strain, for commercial use. 2. portfolio for the purification of peptides and peptide hormones and enhances our ability to offer a complete system solution to our biopharmaceutical customers" said Peter Ehrenheim, Executive Vice President of Separations at Amersham Pharmacia Biotech. "Dan-Process's products complement our Bioprocess portfolio and in combination with our SOURCE(TM) media, they will enhance our capability to support our customers with high-performance solutions for the large-scale production of biopharmaceuticals." "We are very enthusiastic about joining the Amersham Pharmacia Biotech organization, with its long-standing reputation for excellence in protein separations and an extensive global infrastructure and sales network." said Peder Dahl, founder of Dan-Process. "Our know-how and engineering excellence in the area of chromatography equipment will be a great asset in combination with Amersham Pharmacia Biotech's extensive experience." Amersham Pharmacia Biotech, the life sciences business of Nycomed Amersham plc (NYSE NYSE See: New York Stock Exchange : NYE n. 1. A brood or flock of pheasants. Eye, Nye a brood of pheasants. Nye a brood of pheasants—Bk. of St. Albans, 1486. See also eye. )(LSE LSE - Language Sensitive Editor :NAM)(OSE OSE - Open Systems Environment :NYA NYA National Youth Agency (UK) NYA Not Yet Available NYA National Youth Administration NYA Need Your Advice NYA National Yogurt Association NYA New York and Atlantic Railway NYA New York Angels NYA New York Architects ), is a leading global provider of biotechnology systems, products and services for research into genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Pharmacia Biotech's products and technology are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. For more information about Amersham Pharmacia Biotech, please visit http://www.apbiotech.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion